Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New HDAC6 inhibitors identified at Chong Kun Dang Pharmaceutical

Sep. 28, 2021

Neddylation inhibition identified as a means of treating malignant rhabdoid tumors

Sep. 27, 2021

NLRP3 inflammasome inhibitors patented by Cadila Healthcare

Sep. 27, 2021

Japan Tobacco describes new PDHK2 inhibitors

Sep. 27, 2021

OncoNano expands research collaboration with UTSW on novel cancer therapeutics

Sep. 23, 2021

ShanghaiTech University describes IKZF1/IKZF3 degradation inducers

Sep. 23, 2021

Shanghai Zheye Biotechnology patents G12C mutant GTPase KRAS inhibitors

Sep. 23, 2021

Theragnostics and AAA to jointly develop Ga-68 one-step PET radiopharmaceuticals

Sep. 22, 2021

Discovery of novel BRAF dimer inhibitors with promising efficacy

Sep. 22, 2021

Fochon Pharmaceuticals describes CDK2/CDK4/CDK6 inhibitors

Sep. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.